secwatch.observer — SEC 8-K summary
======================================

Issuer:     NOVAVAX INC (NVAX)
CIK:        0001000694
Form:       8-K
Filed at:   2024-05-23T23:59:59+00:00
Accession:  0001104659-24-064680
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Novavax President of R&D Filip Dubovsky to retire effective June 30, 2024
-------------------------------------------------------------------------

- Dubovsky retires as President, R&D effective June 30, 2024.
- Will provide consulting services for 12 months post-retirement at $15,000/month.
- Company will pay COBRA premiums for up to 11 months.
- Equity awards continue to vest during consulting period; unexercised options exercisable 90 days after.
- Non-competition and non-solicitation covenants commence upon retirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000694/000110465924064680/0001104659-24-064680-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000694/000110465924064680/tm2415419d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-064680

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer